Cellebrite DI Ltd. (NASDAQ: CLBT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Greenhaven Road Capital: Cellebrite (CLBT) has a Decade-Long History of Growing Quickly and Profitably [Yahoo! Finance]
SMGZY or CLBT: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
Cellebrite DI Ltd. (NASDAQ:CLBT) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Lake Street Capital from $17.00 to $26.00. They now have a "buy" rating on the stock.